Add to ORKGThe main objective of this study was to investigate whether patients with chronic myeloid leukemia (CML) in treatment with long-term therapy imatinib have a different health-related quality-of-life (HRQOL) profile compared with the general population. In total, 448 CML patients were enrolled, and the SF-36 Health Survey was used to compare generic HRQOL profiles. The HRQOL of CML patients is comparable with that of population norms in many areas, however, younger and female patients seem to report the major limitations
Explore patient-reported outcomes (PROs), including health-related quality of life (HRQoL), satisfac...
Health-related quality of life (HRQOL) is increasingly reported as an important outcome in cancer cl...
Background Health-related quality of life (HRQOL) is a key aspect for chronic myeloid leukemia (CML)...
The main objective of this study was to investigate whether patients with chronic myeloid leukemia (...
The main objective of this study was to investigate whether patients with chronic myeloid leukemia (...
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with...
Background: While Imatinib (IM) has revolutionized treatment for chronic myeloid leukemia (CML), de...
There is paucity of evidence-based data on health-related quality of life (HRQOL) outcomes of chroni...
Health-related quality of life (HRQOL) is an important goal of therapy for chronic myeloid leukemia ...
To evaluate and compare the health-related quality of life (HRQOL) of patients with newly diagnosed ...
The objective of this study was to investigate the health-related quality of life (HRQOL) aspects va...
The main objective of this systematic review is to quantify and to summarize all studies that have i...
Although a wealth of efficacy and safety data is available for many tyrosine kinase inhibitors used ...
The objective of this study was to investigate the health-related quality of life (HRQOL) aspects va...
Purpose: This study aims to evaluate the quality of life (QoL) of chronic myeloid leukemia (CML) pat...
Explore patient-reported outcomes (PROs), including health-related quality of life (HRQoL), satisfac...
Health-related quality of life (HRQOL) is increasingly reported as an important outcome in cancer cl...
Background Health-related quality of life (HRQOL) is a key aspect for chronic myeloid leukemia (CML)...
The main objective of this study was to investigate whether patients with chronic myeloid leukemia (...
The main objective of this study was to investigate whether patients with chronic myeloid leukemia (...
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with...
Background: While Imatinib (IM) has revolutionized treatment for chronic myeloid leukemia (CML), de...
There is paucity of evidence-based data on health-related quality of life (HRQOL) outcomes of chroni...
Health-related quality of life (HRQOL) is an important goal of therapy for chronic myeloid leukemia ...
To evaluate and compare the health-related quality of life (HRQOL) of patients with newly diagnosed ...
The objective of this study was to investigate the health-related quality of life (HRQOL) aspects va...
The main objective of this systematic review is to quantify and to summarize all studies that have i...
Although a wealth of efficacy and safety data is available for many tyrosine kinase inhibitors used ...
The objective of this study was to investigate the health-related quality of life (HRQOL) aspects va...
Purpose: This study aims to evaluate the quality of life (QoL) of chronic myeloid leukemia (CML) pat...
Explore patient-reported outcomes (PROs), including health-related quality of life (HRQoL), satisfac...
Health-related quality of life (HRQOL) is increasingly reported as an important outcome in cancer cl...
Background Health-related quality of life (HRQOL) is a key aspect for chronic myeloid leukemia (CML)...